Cite
HARVARD Citation
Patrawala, S. et al. (2012). Vemurafenib (RG67204, PLX4032): a potent, selective BRAF kinase inhibitor. Future oncology. pp. 509-523. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Patrawala, S. et al. (2012). Vemurafenib (RG67204, PLX4032): a potent, selective BRAF kinase inhibitor. Future oncology. pp. 509-523. [Online].